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Lee Hartwell: rebel
with a cause
Jim Kling
Lee Hartwell is the new director of
the Fred Hutchinson Cancer
Research Center (‘the Hutch’) in
Seattle, Washington. It’s hard to
believe that this adroit and soft-
spoken man was once a “tearaway”
— cruising the streets of 1950s Los
Angeles with his high school gang,
and sporting a black wool jacket with
a dragon emblem. Though there’s
still something of the maverick in
him, he grew tired of the gang
lifestyle in high school, and went on
to fall in love with biology in college,
becoming absorbed by the cell cycle
and the genetics that control it.
His work at the University of
Washington, where he has been for
the past 30 years, has earned him a
reputation as a ‘scientist’s scientist’;
he is widely admired for his brilliant,
if sometimes impenetrable, research.
Hartwell was the first to demonstrate,
in the 1960s, that the cell cycle in
yeast cells is genetically controlled.
He also documented the existence of
cell-cycle checkpoints — control
mechanisms that ensure a given stage
in cell division has been completed
before the next stage begins.
More recently, Hartwell has
suggested a role for checkpoint
defects and genetic instability in
cancer progression, and has proposed
how to exploit these defects to
devise rational cancer therapies. “For
over 30 years, a majority of the key
insights into the cell cycle have been
made by [him],” according to Mark
Groudine, director of the basic
sciences division at the Hutch.
Doug Koshland, a geneticist at
the Carnegie Institute in Baltimore
and former post-doc of Hartwell’s,
recalls him as a deep thinker. “You’d
tell him something, and you would
not necessarily get an immediate
response — you might even think he
hadn’t been paying attention to you.
Then three or four days later he’d
come back and tell you what he
thought. You could tell he’d thought
really hard about the problem.”
The yeast cell cycle work helped
set the stage for an explosion in
human cancer research when, in a
1987 article in Nature, Paul Nurse
announced that the human
homologue of the CDC2 gene —
which encodes a protein kinase that
is essential to the cell cycle in yeast
— would function when transfected
into yeast cells that lacked the gene.
Soon others confirmed that many
human homologues of yeast genes
perform the same functions, and a
wealth of information gleaned from
yeast cells was suddenly directly
applicable to the study of human cell
division — and cancer. Though the
discoveries were as much of a
surprise to him as to the rest of the
research world, in hindsight,
Hartwell says they shouldn’t have
been. “The metabolic pathways are
all the same, why shouldn’t the
[signal pathways that lead to cell
division] be the same?”
The revelation that the yeast
model had so much to offer caused
great excitement, but Hartwell
realized the time had come to move
past these simplified systems. “I
came to the conclusion that human
biology would only become clearer
through a real combination of three
disciplines: basic science, clinical
sciences, and the population
sciences.” A year ago, Hartwell joined
the Hutch, to embark on what he
calls his “sociological experiment.”
Dubbed by Hartwell the Inter-
divisional Research and Training
Initiative, it called for meetings and
retreats to bring researchers from
these diverse disciplines together for
a view of “the big picture” of cancer.
The approach made an
impression on Ross Prentice, director
of the public health division at the
Hutch. “It was refreshing to me that
a senior person with a very
substantial reputation as a basic
biological scientist was willing to
move his base to [the Hutch] and
commit half of his time to
interdisciplinary research program
development . . . as scientists we tend
to have the knee-jerk reaction that
whatever we don’t know about can’t
be important, so it takes somebody
with confidence to step out and
endorse the groups and areas that
they are not a part of,” says Prentice.
Hartwell is now playing an even
larger role. This month, he took over
from the director of the past 16 years,
Robert W. Day. Hartwell figures that
the invitation to take over the
directorship was a indication that the
institution wanted to emphasize
communication between the
disciplines “. . . certainly, if they
wanted a strong administrator, I don’t
have a track record [as one],” he says. 
Many at the Hutch believe
Hartwell’s tenure will bring changes
in the atmosphere and research
directions. The molecular medicine
division — dwarfed by the Center’s
larger public health, clinical research,
and basic science divisions — seems
especially likely to thrive, as the
approach of its scientists seems tailor-
made to Hartwell’s interdisciplinary
vision.
Hartwell is ready to get stuck in:
“The next thing to do is roll up our
sleeves, and we’ll make a real impact
on cancer.”
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